Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

544 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pyrazine-based Syk kinase inhibitors.
Forns P, Esteve C, Taboada L, Alonso JA, Orellana A, Maldonado M, Carreño C, Ramis I, López M, Miralpeix M, Vidal B. Forns P, et al. Among authors: vidal b. Bioorg Med Chem Lett. 2012 Apr 15;22(8):2784-8. doi: 10.1016/j.bmcl.2012.02.087. Epub 2012 Mar 2. Bioorg Med Chem Lett. 2012. PMID: 22425453
Novel triazolopyridylbenzamides as potent and selective p38α inhibitors.
Aiguadé J, Balagué C, Carranco I, Caturla F, Domínguez M, Eastwood P, Esteve C, González J, Lumeras W, Orellana A, Preciado S, Roca R, Vidal L, Vidal B. Aiguadé J, et al. Among authors: vidal l, vidal b. Bioorg Med Chem Lett. 2012 May 15;22(10):3431-6. doi: 10.1016/j.bmcl.2012.03.099. Epub 2012 Apr 4. Bioorg Med Chem Lett. 2012. PMID: 22521646
Highly potent aminopyridines as Syk kinase inhibitors.
Castillo M, Forns P, Erra M, Mir M, López M, Maldonado M, Orellana A, Carreño C, Ramis I, Miralpeix M, Vidal B. Castillo M, et al. Among authors: vidal b. Bioorg Med Chem Lett. 2012 Sep 1;22(17):5419-23. doi: 10.1016/j.bmcl.2012.07.045. Epub 2012 Jul 20. Bioorg Med Chem Lett. 2012. PMID: 22877633
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists I.
Alonso JA, Andrés M, Bravo M, Buil MA, Calbet M, Castro J, Eastwood PR, Eichhorn P, Esteve C, Gómez E, González J, Mir M, Petit S, Roberts RS, Vidal B, Vidal L, Vilaseca P, Zanuy M. Alonso JA, et al. Among authors: vidal l, vidal b. Bioorg Med Chem Lett. 2014 Nov 1;24(21):5118-22. doi: 10.1016/j.bmcl.2014.09.005. Epub 2014 Oct 15. Bioorg Med Chem Lett. 2014. PMID: 25437504
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists II: lead optimization.
Alonso JA, Andrés M, Bravo M, Calbet M, Eastwood PR, Eichhorn P, Esteve C, Ferrer M, Gómez E, González J, Mir M, Moreno I, Petit S, Roberts RS, Sevilla S, Vidal B, Vidal L, Vilaseca P, Zanuy M. Alonso JA, et al. Among authors: vidal l, vidal b. Bioorg Med Chem Lett. 2014 Nov 1;24(21):5123-6. doi: 10.1016/j.bmcl.2014.08.029. Epub 2014 Aug 19. Bioorg Med Chem Lett. 2014. PMID: 25437505
544 results